Paradoxical Effects of Viscosity on the VentrAssist Rotary
Blood Pump
*S. Vidakovic, *P. Ayre, *J. Woodard, *N. Lingard, †G. Tansley, and †J. Reizes
*VentrAssist P/L and †University of Technology, Sydney, Australia
Abstract: The ability of the VentrAssist blood pump to
perform at its optimum design point is determined by a
number of factors such as geometry of the pump, surface
roughness, and fluid properties. Once the fluid properties
are known, the performance characteristics of the pump
can be optimized for that fluid. It is important to under-
stand the effects of dynamic viscosity (called simply vis-
cosity hereafter) on the performance characteristics and
stability of the pump. The performance envelope of the
pump and the needs of the patient must be matched. The
VentrAssist pump has no shaft, seals, or fixed bearings and
relies on the fluid-dynamic forces to maintain its effective
performance. A number of different fluids have been
tested to determine the effects of viscosity and density on
pump performance. These include aqueous glycerol, red
blood cells (RBCs) suspended in phosphate buffered sa-
line solution (PBS), and Haemaccel. The effects of viscos-
ity on the bearing stiffness, stage efficiency, and the pres-
sure-flow rate (HQ) are characterized. The experimental
results show a slight increase in the pressure rise across
the pump shown as a positive upward shift of the H-Q
curves with a decrease in viscosity; however, this is rela-
tively small. A paradox in system efficiency exists: for a
given fluid asymptotic viscosity, the system efficiency
(product of magnetic and stage efficiency) using Haemac-
cel or PBS is greater than for the same viscosity of aqueous
glycerol. Key Words: Rotary blood pump—VentrAs-
sist—Viscosity.
Viscosity has been identified as an important pa-
rameter for the stable operation (1) of the VentrAs-
sist implantable rotary blood pumps (IRBP) (Fig. 1).
Stability is not a concern in shafted pumps with fixed
bearings (2) because the rotor is restrained mechani-
cally, or in magnetically suspended rotors because
they do not depend on the fluid properties to main-
tain their position within the housing (3). The hydro-
dynamic surfaces in a VentrAssist IRBP produce lift
on top and bottom surfaces and balance the rotor in
the housing. Rotor stiffness is determined by the vis-
cosity of the fluid tested (Fig. 2), the gap between the
moving and stationary surfaces, surface roughness,
and the taper on the hydrodynamic wedge (Fig. 3).
A shafted version of the VentrAssist IRBP was
used to measure the stage efficiency of a number of
rotor designs to determine the optimum stage effi-
ciency. The loop in this circuit was kept to a mini-
mum to maintain a minimum pressure drop across
the circuit to extend the range of useful data. Only
nonbiological fluids were tested in this loop. The
mock loop built to ASTM requirements was used to
evaluate all fluids, including biological fluids using
the VentrAssist IRBP.
MATERIALS AND METHODS
To determine the effects of viscosity on the system
efficiency and stage efficiency of the VentrAssist
IRBP, steady flow tests were carried out using aque-
ous glycerol and red cell suspension of human blood
with a range of HCT in phosphate buffered saline
solution (PBS) and Haemaccel (Fig. 4). The ASTM
mock loop was used for testing all fluids whereas the
shorter loops were used specifically for the nonbio-
logical fluids and with the shafted version of the
VentrAssist IRBP.
The shafted version of the pump consists of a
pump machined from an acrylic block such that the
flow inside the pump can be visualized for particle
tracing (PT) and particle image velocimetry (PIV).
The rotor is mounted on a shaft and fitted with bear-
Received December 1999.
Presented in part at the 7th Congress of the International So-
ciety for Rotary Blood Pumps, held August 26–27, 1999, in Tokyo,
Japan.
Address correspondence and reprint requests to Dr. Geoff
Tansley, VentrAssist, 126 Greville Street, Chatswood 2067 NSW,
Australia. E-mail: geoff.tansley@ventrassist.com
Artificial Organs
24(6):478–482, Blackwell Science, Inc.
© 2000 International Society for Artificial Organs
478